Reaction

Dyspnoea Exacerbated reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 515 reports · 8 co-occurring drugs

As of the last recalculation, Dyspnoea Exacerbated appears in 515 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 128.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Salmeterol Xinafoate26128.3128.7
Tiotropium Bromide14961.561.5
Theophylline1243.243.2
Theophylline Anhydrous1240.040.1
Ipratropium Bromide3036.036.1
Calcium Gluconate1034.234.2
Bosentan3429.129.1
Gefitinib627.227.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.